Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Sheremata

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neurologic Clinics|November 29, 2012
Multiple sclerosis and the spinal cordWilliam Sheremata, Leticia Tornes
Neurologic Clinics|December 3, 2014
Multiple sclerosis and the cerebellumLeticia Tornes, Brittani Conway, William Sheremata
Expert Opinion on Drug Safety|November 11, 2014
Dimethyl fumarate for treating relapsing multiple sclerosisWilliam Sheremata, Andrew D Brown, Kottil W Rammohan
Journal of Clinical Neuromuscular Disease|June 6, 2008
Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosisKhema R Sharma, Daniela Saadia, Alicia G Facca, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosisPaul O'Connor, David Miller, Katherine Riester, et al.
Virology Journal|December 25, 2013
Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathyRaisa Perzova, Elliot Graziano, Swathi Sanghi, et al.
AIDS Research and Human Retroviruses|October 9, 2014
Increased seroreactivity to human T cell lymphoma/leukemia virus-related endogenous sequence-1 Gag peptides in patients with human T cell lymphoma/leukemia virus myelopathyRaisa Perzova, Elliot Graziano, Swathi Sanghi, et al.
AIDS Research and Human Retroviruses|January 6, 2010
LGL leukemia and HTLVAnish Thomas, Raisa Perzova, Lynn Abbott, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neurologic Clinics|November 29, 2012
Multiple sclerosis and the spinal cordWilliam Sheremata, Leticia Tornes
Neurologic Clinics|December 3, 2014
Multiple sclerosis and the cerebellumLeticia Tornes, Brittani Conway, William Sheremata
Expert Opinion on Drug Safety|November 11, 2014
Dimethyl fumarate for treating relapsing multiple sclerosisWilliam Sheremata, Andrew D Brown, Kottil W Rammohan
Journal of Clinical Neuromuscular Disease|June 6, 2008
Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosisKhema R Sharma, Daniela Saadia, Alicia G Facca, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosisPaul O'Connor, David Miller, Katherine Riester, et al.
Virology Journal|December 25, 2013
Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathyRaisa Perzova, Elliot Graziano, Swathi Sanghi, et al.
AIDS Research and Human Retroviruses|October 9, 2014
Increased seroreactivity to human T cell lymphoma/leukemia virus-related endogenous sequence-1 Gag peptides in patients with human T cell lymphoma/leukemia virus myelopathyRaisa Perzova, Elliot Graziano, Swathi Sanghi, et al.
AIDS Research and Human Retroviruses|January 6, 2010
LGL leukemia and HTLVAnish Thomas, Raisa Perzova, Lynn Abbott, et al.
Pageof 1